Genetic Technologies Appoints Mark Ziirsen as Chief Financial Officer & Company Secretary
Position
Company Secretary
Company
Genetic Technologies Limited
Description
Genetic Technologies Limited is pleased to announce the appointment of Mark Ziirsen as Chief Financial Officer (CFO) and Company Secretary. Mark Ziirsen is a globally experienced ASX and Nasdaq listed CFO with more than 25 years’ experience operating across life sciences, technology, and consumer segments.
Quick answer
Genetic Technologies Appoints Mark Ziirsen as Chief Financial Officer & Company Secretary (July 16, 2024). Genetic Technologies Limited is based in Melbourne, Victoria, Australia.
- Who is the new Company Secretary at Genetic Technologies Limited?
- Genetic Technologies Limited named Mark Ziirsen Company Secretary, announced July 16, 2024.
- What did Genetic Technologies Limited announce on July 16, 2024?
- Genetic Technologies Limited is pleased to announce the appointment of Mark Ziirsen as Chief Financial Officer (CFO) and Company Secretary. Mark Ziirsen is a globally experienced ASX and Nasdaq listed CFO with more than 25 years’ experience operating across life sciences, technology, and consumer segments.
- What does Genetic Technologies Limited do?
- Genetic Technologies Limited is a diversified molecular diagnostics company, a global leader in genomics-based tests in health, wellness, and serious disease through its geneType and EasyDNA brands.
- Where is Genetic Technologies Limited based?
- Genetic Technologies Limited is based in Melbourne, Victoria, Australia.
- Which similar companies made leadership changes around the same time?
- Insight Molecular Diagnostics Inc. (June 17, 2024), Mosaic Diagnostics (June 27, 2024), Blackford Analysis (June 27, 2024) and Element Biosciences (June 26, 2024) also announced leadership changes within 45 days of Genetic Technologies Limited.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Health Diagnostics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Oncocyte Corporation Appoints Andrea James as Chief Financial Officer and Principal Financial Officer (June 17, 2024)
- Mosaic Diagnostics Appoints Rob Rebak as Chief Executive Officer (June 27, 2024)
- Blackford Welcomes Chris Meenan as Chief Product Officer (June 27, 2024)
- Element Biosciences Appoints Amirali Kia, PhD as Vice President of Artificial Intelligence and Tina Tian, PhD as Vice President of Portfolio Management (June 26, 2024)
- ENDRA Life Sciences Inc. Appoints Alexander Tokman as Acting Chief Executive Officer and Adds Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer (August 13, 2024)
- Ultima Genomics Hires Chris Seipert as Senior Vice President of Operations and Lara Toerien as Vice President of Sales, North America (August 13, 2024)
Who to call at Genetic Technologies Limited, and when
A new leader at Genetic Technologies Limited brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Genetic Technologies Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genetic Technologies Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genetic Technologies Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genetic Technologies Limited changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Genetic Technologies Limited changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.